Interferon alfa-2b (Anhui Anke Biotechnology)

干扰素α-2b（安科生物）

Report date: 2026/04/28 20:00:22

Base Information

Drug NameInterferon alfa-2b (Anhui Anke Biotechnology)
Drug Alias NameRecombinant interferon alpha-2b (Anhui Anke Biotechnology)安达芬rHuIFNa-2b
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsUterine Cervical ErosionLeukemia, Myelogenous, ChronicLeukemia, Hairy Cell +[11] 
Global Approved IndicationsUterine Cervical ErosionLeukemia, Myelogenous, ChronicLeukemia, Hairy Cell +[10] 
Approved Indications in ChinaUterine Cervical ErosionLeukemia, Myelogenous, ChronicLeukemia, Hairy Cell +[10] 
Original Approved Country/TerritoryMainland China
Original Approved Date1997/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAnhui Anke Biotechnology (Group) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAnhui Anke Biotechnology (Group) Co Ltd
Inactive CompaniesN/A
Active IndicationsUterine Cervical ErosionLeukemia, Myelogenous, ChronicLeukemia, Hairy Cell +[11] 
Inactive IndicationsN/A

Other Information

ATC CodeL03AB05
Related LinksN/A